Navigation Links
Samarion Praises Congress for Passage of Safety for Seniors Act of 2008
Date:6/18/2008

CEO Mark Rodgers Urges Appropriations Committee to Fully Fund the National

Injury Prevention Program

WASHINGTON, June 18 /PRNewswire-USNewswire/ -- Samarion CEO Mark Rodgers applauds Congress for passing the Safety for Seniors Act of 2008 and urges lawmakers to provide the necessary funding for the Centers for Disease Control's (CDC's) Injury Center to fully implement this critical fall prevention initiative.

"Millions of the nation's elderly, and their families, suffer the terrible consequences of falls each year," said Rodgers, "and while more than $19 billion is spent annually after-the-fact, the impact on these frail seniors cannot be measured in dollars alone. As a nation, we must do more to prevent these falls from occurring and reverse this serious healthcare crisis."

Samarion joins more than 30 national policy organizations calling on Congress to fully fund the Safety for Seniors Act of 2008, signed into law by President George W. Bush in late April. Now titled Public Law 110-202, the act will develop education strategies to raise awareness about elder falls, encourage research to identify at-risk populations and evaluate falls interventions, and very importantly, support fall prevention demonstration projects.

"Right now, new technologies are demonstrating their effectiveness at actually preventing falls from occurring in the first place," continued Rodgers. "Funding the CDC's Injury Center will provide the means to roll out important pilot programs to validate these promising fall prevention technologies."

Samarion is the developer of SamarionSolution(SM), the nursing home and assisted living industry's Enterprise Quality Improvement System, including restraint-free fall prevention, wandering and elopement prevention, abuse and neglect prevention, and family and community communications providing dramatically improved quality of life for the elderly and their caregivers.

Press Release Disclaimer

Please note that this press release was created as of the date listed, and reflected management views as of that date. This press release includes and is based, inter alia, upon forward-looking information and statements that are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Such forward-looking information and statements are based on current expectations, estimates, and projections. Important factors that could cause actual results to differ materially from those expectations include, but are not limited to, market acceptance of new products and services, changes in governmental regulations, and such other factors as may be discussed from time to time. Although Samarion believes that its expectations and the information in this press release were based upon reasonable assumptions at the time it was made, it can give no assurance that those expectations will be achieved or that the actual results will be as set out in this press release. Samarion undertakes no obligation to publicly update or revise any forward-looking information or statements in this press release, which speaks as of its respective date.


'/>"/>
SOURCE Samarion
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Samarion(SM) Announces Formation of Outcome Based Study Team for Industrys Only Enterprise Quality Improvement System
2. Samarion(SM) Announces Second Outcome Based Study Partner Site for LTC Industrys Only Enterprise Quality Improvement System
3. AHIP Praises Bipartisan Senate Vote on Mental Health Parity
4. Union President Praises Hillary Clintons Health Plan
5. AIDS Action Council Praises Release of Latest State of AIDS in Black America Report
6. Lung Cancer Alliance Praises Congressional Call for Increased Commitment to Fund Lung Cancer Research
7. Bishops Conference Praises Senate Introduction of Pregnant Women Support Act
8. American Life League Praises Colorado Efforts to Stop Planned Parenthood Abortion Facility
9. Alliance for Quality Nursing Home Care Praises CMS Release of Updated Special Focus Facilities (SFF) List
10. Blunt Praises Presidents Plan to Save Medicare
11. FRC Action Praises John McCains Pro-Life Comments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... May 06, 2016 , ... Kenneth Cochran, DSc, RN, FACHE, ... of the South announced today that Dr. Robert Menuet, Interventional Cardiologist with Cardiovascular ... Ultrasound Guided Coronary Atherectomy. , This procedure involves the removal of ...
(Date:5/5/2016)... ... May 05, 2016 , ... TransWipe Volume 3 is ... X. Drag and drop a TransWipe preset between two video clips to instantly add ... wipes to colored panels with customizable color and orientation options. TransWipe Volume 3 is ...
(Date:5/5/2016)... ... 2016 , ... Qrono Inc. , a specialty pharmaceutical ... with the Australian critical medicine company, Phebra Pty Ltd. , to develop ... can offer improved therapeutic benefits over oral formulations, including better bioavailability, improved adherence, ...
(Date:5/5/2016)... ... May 05, 2016 , ... Einstein Medical is proud ... cover the latest news and commentary at the 2016 ASCRS/ASOA Symposium and Congress, which ... American Society of Cataract and Refractive Surgery and the American Society of Ophthalmic Administrations ...
(Date:5/5/2016)... ... ... weekend, from Friday, May 6 - Sunday, May 8, fifteen elite athletes from Team ... Fi Mountain Bike Camp, hosted in conjunction with WTB and Cannondale ... Moeschler, who’ll share pro tips with the injured veterans as they rip down some of ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... ALBANY, New York , May 4, 2016 /PRNewswire/ ... published by Transparency Market Research entitled "Brain Computer Interface Market ... Forecast 2016 - 2024," the  global brain computer interface (BCI) ... bn by 2024. The market is estimated to expand ... period from 2016 to 2024. A BCI ...
(Date:5/4/2016)... -- Yissum Research Development Company of ... it had signed an exclusive world-wide licensing and research ... protein degradation and immunomodulatory drugs for cancer and immune ... representing first-in-class therapy for hematologic and solid malignancies. Financial ... The novel technology was developed by Yinon Ben-Neriah ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Acute Ischemic Stroke Market ... to their offering.       (Logo: ... Global Acute Ischemic Stroke Market and Competitive ... Acute Ischemic Stroke pipeline products, Acute Ischemic ...
Breaking Medicine Technology: